Ebola Literature

Abramowitz SA, Hipgrave DB, Witchard A, et al. Lessons from the West Africa Ebola epidemic: a systematic review of epidemiological and social behavioral science research priorities. J Infect Dis 2018 (published online Jun 23)

Barry A, Ahuka-Mundeke S, Ahmed YA, et al (Ebola Outbreak Epidemiology Team). Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April-May, 2018: an epidemiological study. Lancet 2018 (published online Jun 29)

Billioux BJ, Nath A, Stavale EJ, et al. Cerebrospinal fluid examination in survivors of Ebola virus disease. (Letter) JAMA Neurol 2017 (published online Jul 17)

Brown JF, Dye JM, Tozay S, et al. Anti-Ebola virus antibody levels in convalescent plasma and viral load after plasma infusion in patients with Ebola virus disease. J Infect Dis 2018 (published online Apr 11)

Caceres VM, Sidibe S, Andre M, et al. Surveillance training for Ebola preparedness in Cote d'lvoire, Guinea-Bissau, Senegal, and Mali. Emerg Infect Dis 2017 (published online Nov 7)

Caleo G, Duncombe J, Jephcott F, et al. The factors affecting household transmission dynamics and community compliance with Ebola control measures: a mixed-methods study in a rural village in Sierra Leone. BMC Public Health 2018 Feb 13;18:248

Carter RJ, Idriss A, Widdowson MA, et al. Implementing a multisite clinical trial in the midst of an Ebola outbreak: lessons learned from the Sierra Leone Trial to Introduce a Vaccine against Ebola. J Infect Dis 2018 May 18;217(suppl 1):S16-23

Carter RJ, Senesi RGB, Dawson P, et al. Participant retention in a randomized clinical trial in an outbreak setting: lessons from the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE). J Infect Dis 2018 May 18;217(suppl 1):S65-74

Casanova LM, Erukunuakpor K, Kraft CS, et al. Assessing viral transfer during doffing of Ebola-level personal protective equipment in a biocontainment unit. Clin Infect Dis 2018 (published online Feb 17)

Cherif MS, Dumre SP, Kasse D, et al. Prognostic and predictive factors of Ebola virus disease outcome in elderly people during the 2014 outbreak in Guinea. Am J Trop Med Hyg 2017 (published online Oct 30)

Conteh MA, Goldstein ST, Wurie HR, et al. Clinical surveillance and evaluation of suspected Ebola cases in a vaccine trial during an Ebola epidemic: the Sierra Leone Trial to Introduce a Vaccine against Ebola. J Infect Dis 2018 May 18;217(suppl 1):S33-9

Crook P, Smith-Palmer A, Maguire H, et al. Lack of secondary transmission of Ebola virus from healthcare worker to 238 contacts, United Kingdom, December 2014. Emerg Infect Dis 2017 (published online Nov 2)

Dalziel BD, Lau MSY, Tiffany A, et al. Unreported cases in the 2014-2016 Ebola epidemic: spatiotemporal variation, and implications for estimating transmission. PLoS Negl Trop Dis 2018 Jan 22;12(1):e0006161

Deen GF, Broutet N, Xu W, et al. Ebola RNA persistence in semen of Ebola virus disease survivors — final report. N Engl J Med 2017 Oct 12(15);377:1428-37

Demetria C, Smith I, Tan T, et al. Reemergence of Reston ebolavirus in cynomolgus monkeys, the Philippines, 2015. Emerg Infect Dis 2018 (published online May 22)

Diallo B, Van Gucht S, Musa EO, et al. Ebola virus transmission caused by persistently infected survivors of the 2014-2016 outbreak in West Africa. J Infect Dis 2018 (published online Jun 18)

Dickson SJ, Clay KA, Adam M, et al. Enhanced case management can be delivered for patients with EVD in Africa: experience from a UK military Ebola treatment centre in Sierra Leone. J Infect 2017 (published online Dec 14)

Domi A, Feldmann F, Basu R, et al. A single dose of modified vaccinia Ankara expressing Ebola virus like particles protects nonhuman primates from lethal Ebola virus challenge. Sci Rep 2018 (published online Jan 16)

Eisfeld AJ, Halfmann PJ, Wendler JP, et al. Multi-platform 'omics analysis of human Ebola virus disease. Cell Host Microbe 2017 (published Nov 16)

Fischer WA 2nd, Vetter P, Bausch DG, et al. Ebola virus disease: an update on post-exposure prophylaxis. Lancet Infect Dis 2017 (published online Nov 15)

Fisher WA II, Brown J, Wohl DA, et al. Ebola virus RNA detection in semen more than two years after resolution of acute Ebola virus infection. Open Forum Infect Dis 2017 (published online Jul 22)

Fitzgerald F, Wing K, Naveed A, et al. Development of a pediatric Ebola predictive score, Sierra Leone. Emerg Infect Dis 2018 (published online Jan 4)

Foote M, Daver R, Quinn C. Using "mystery patient" drills to assess hospital Ebola preparedness in New York City, 2014-2015. Health Secur 2017 Oct 1;15(5):500-8

Furuse Y, Fallah M, Oshitani H, et al. Analysis of patient data from laboratories during the Ebola virus disease outbreak in Liberia, April 2014 to March 2015. PLoS Negl Trop Dis 2017 Jul 21;11(7):e0005804

GAO. Ebola recovery: USAID has initiated or completed most projects, but a complete project inventory is still needed for evaluating its efforts. GAO-18-350. Mar 28, 2018

Glynn JR, Bower H, Johnson S, et al. Variability in intra-household transmission of Ebola virus, and estimation of the household secondary attack rate. J Infect Dis 2017 (published online Nov 11)

Gray N, Stringer B, Bark G, et al. 'When Ebola enters a home, a family, a community': a qualitative study of population perspectives on Ebola control measures in rural and urban areas of Sierra Leone. PLoS Negl Trop Dis 2018 Jun 8;12(6):e0006461

Gsell PS, Camacho A, Kucharski AJ, et al. Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report. Lancet Infect Dis 2017 (published online Oct 9)

Guedj J, Piorkowski G, Jacquot F, et al. Antiviral efficacy of favipiravir against Ebola virus: a translational study in cynomolgus macaques. PLoS Med 2018 Mar 27;15(3):e1002535

Hagel C, Weidemann F, Gauch S, et al. Analysing published global Ebola virus disease research using social network analysis. PLoS Negl Trop Dis 2017 Oct 9;11(10):e0005747

Hsu CH, Champaloux SW, Keita S, et al. Sensitivity and specificity of suspected case definition used during West Africa Ebola epidemic. Emerg Infect Dis 2017 (published online Nov 28)

Huttner A, Agnandji ST, Combescure C, et al. Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study. Lancet Infect Dis 2018 (published online Apr 4)

Irwin KL, Jalloh MF, Corker J, et al. Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: results of a national household survey. Vaccine 2017 Dec 14;35(49):6915-23

J Infect Dis. Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE). J Infect Dis supplement 2018 May 18;217(suppl 1)

Jagadesh S, Sevalie S, Fatoma R, et al. Disability among Ebola survivors and their close contacts in Sierra Leone: a retrospective case-controlled cohort study. Clin Infect Dis 2017 (published online Aug 20)

Jalloh MF, Robinson SJ, Corker J, et al. Knowledge, attitudes, and practices related to Ebola virus disease at the end of a national epidemic — Guinea, August 2015. MMWR 2017 Oct 20;66(41):1109-15

James AS, Todd S, Pollak NM, et al. Ebolavirus diagnosis made simple, comparable and faster than molecular detection methods: preparing for the future. Virol J 2018 Apr 23;15:75

Jarrett OD, Seward JF, Fombah AE, et al. Monitoring serious adverse events in the Sierra Leone Trial to Introduce a Vaccine against Ebola. J Infect Dis 2018 May 18:217(suppl 1):S24-32

Jennings BM, Yeager KA, Feistritzer NR, et al. Enacting high reliability principles while caring for people with Ebola virus disease. Am J Infect Control 2018 (published online May 18)

Jusu MO, Glauser G, Seward JF, et al. Rapid establishment of a cold chain capacity of -60˚C or colder for the STRIVE Ebola vaccine trial during the Ebola outbreak in Sierra Leone. J Infect Dis 2018 May 18;217(suppl 1):S48-55

Kelly JD, Barrie MB, Mesman AW, et al. Anatomy of hotspot: chain and seroepidemiology of Ebola virus transmission, Sukudu, Sierra Leone, 2015-16. J Infect Dis 2018 (published online Jan 9)

Kennedy SB, Bolay F, Kieh M, et al. Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia. N Engl J Med 2017 Oct 12;377(15):1438-47

Lamontagne F, Fowler RA, Adhikari NK, et al. Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet 2017 (published online Oct 17)

Lanini S, Portella G, Vairo F, et al. Relationship between viremia and specific organ damage in Ebola patients: a cohort study. Clin Infect Dis 2017 (published online Aug 20)

Lee H, Nishiura H. Recrudescence of Ebola virus disease outbreak in West Africa, 2014–2016. Int J Infect Dis 2017 (published online Sep 19)

Lyman M, Mpofu JJ, Soud F, et al. Maternal and perinatal outcomes in pregnant women with suspected Ebola virus disease in Sierra Leone, 2014. Obstet Gynecol 2018 (published online Mar 23)

Mallow M, Gary L, Jeng T, et al. WASH activities at two Ebola treatment units in Sierra Leone. PLoS One 2018 May 24;13(5):e0198235

Marston BJ, Dokubo EK, van Steelandt A, et al. Ebola response impact on public health programs, West Africa, 2014-2017. Emerg Infect Dis 2017 (published online Nov 15)

Marz A, Chadinah S, Haddock E, et al. Recently identified mutations in the Ebola virus-Makona genome do not alter pathogenicity in animal models. Cell Rep 2018 May 8;23(6):1806-16

Mayrhuber EAS, Niederkrotenthaler T, Kutalek R. "We are survivors and not a virus": content analysis of media reporting on Ebola survivors in Liberia. PLoS Negl Trop Dis 2017 Aug 24;11(8):e0005845

Meyer D, Sell TK, Schoch-Spana M, et al. Lessons from the domestic Ebola response: improving health care system resilience to high consequence infectious diseases. Am J Infect Control 2017 (published online Dec 15)

Mobula LM, MacDermott N, Hoggart C, et al. Clinical manifestations and modes of death among patients with Ebola virus disease, Monrovia, Liberia, 2014. Am J Trop Med Hyg 2018 (published online Feb 5)

Molinari NAM, LeBlanc TT, Stephens W. The impact of a case of Ebola virus disease on emergency department visits in metropolitan Dallas-Fort Worth, TX, July, 2013-July, 2015: an interrupted time series analysis. PLoS Curr 2018 Mar 20

Mulangu S, Alfonso VH, Hoff NA, et al. Serologic evidence of Ebolavirus infection in a population with no history of outbreaks in the Democratic Republic of the Congo. J Infect Dis 2018 (published online Jan 10)

Mumma JM, Durso FT, Ferguson AN, et al. Human factors risk analyses of a doffing protocol for Ebola-level personal protective equipment: mapping errors to containment. Clin Infect Dis 2018 (published online Feb 17)

Narra R, Sobel J, Piper C, et al. CDC safety training course for Ebola virus disease healthcare workers. Emerg Infect Dis 2017 (published online Nov 13)

Odlum M, Yoon S. Health information needs and health seeking behavior during the 2014-2016 Ebola outbreak: a Twitter content analysis. PLoS Curr 2018 (published online Mar 23)

Oza S, Sesay AA, Russell NJ, et al. Symptom- and laboratory-based Ebola risk scores to differentiate likely Ebola infections. Emerg Infect Dis 2017 (published online Oct 16)

Oza S, Sesay AA, Russell NJ, et al. Symptom- and laboratory-based Ebola risk scores to differentiate likely Ebola infections. Emerg Infect Dis 2017 (published online Oct 4)

Pascal KE, Dudgeon D, Trefry JC, et al. Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in non-human primates. J Infect Dis 2018 (published online May 31)

Pascal KE, Dudgeon D, Trefry JC, et al. Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in non-human primates. J Infect Dis 2018 (published online May 31)

Perry DL, Huzella LM, Bernbaum JG, et al. Ebola virus localization in the macaque reproductive tract during acute Ebola virus disease. Am J Pathol 2018 (published online Feb 8)

Petersen J, Simons H, Patel D. Amplification of perceived risk among users of a national travel health Web site during the 2013-2016 West African Ebola virus outbreak. Am J Infect Control 2018 (published online Jan 2)

Pierce WF, Ready SD, Chapman JT, et al. Essential medications for patients with suspected or confirmed Ebola virus disease in resource-limited environments. Mil Med 2017 Sep;182(9):e2006-16

Pini A, Zomahoun D, Duraffour S, et al. Field investigation with real-time virus genetic characterization support of a cluster of Ebola virus disease cases in Dubreka, Guinea, April to June 2015. Euro Surveill 2018 Mar 22;23(12):pii=17-00140

Reichler MR, Bangura J, Bruden D, et al. Household transmission of Ebola virus: risks and preventive factors, Freetown, Sierra Leone, 2015. J Infect Dis 2018 (published online Apr 6)

Reusken CB, Mogling R, Smit PW, et al. Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet. Euro Surveill 2018 May 10;23(19):pii=17-00404

Rimoin AW, Lu K, Bramble MS, et al. Ebola virus neutralizing antibodies detectable in survivors of the Yambuku, Zaire outbreak 40 years after infection. J Infect Dis 2017 (published online Dec 14)

Samai M, Seward JF, Goldstein ST, et al. The Sierra Leone Trial to Introduce a Vaccine Against Ebola: an evaluation of rVSVΔG-ZEBOV-GP vaccine tolerability and safety during the West Africa Ebola outbreak. J Infect Dis 2018 May 18;217(suppl 1):S6-15

Schemm Dwyer K, Misner H, Chang S, et al. An interim examination of the US public health response to Ebola. Health Secur 2017 Oct 1;15(5):517-38

Shantha JG, Mattia JG, Goba A, et al. Ebola virus persistence in ocular tissues and fluids (EVICT) study: reverse transcription-polymerase chain reaction and cataract surgery outcomes of Ebola survivors in Sierra Leone. EBioMedicine 2018 (published online Mar 23)

Sivapalasingam S, Kamal M, Slim R, et al. Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study. Lancet Infect Dis 2018 (published online Jun 18)

Skrable K, Roshania R, Mallow M, et al. The natural history of acute Ebola virus disease among patients managed in five Ebola treatment units in West Africa: a retrospective cohort study. PLoS Negl Trop Dis 2017 Jul 19;11(7):e0005700

Smither SJ, Eastaugh L, Filone CM, et al. Two-center evaluation of disinfectant efficacy against Ebola virus in clinical and laboratory matrices. Emerg Infect Dis 2017 (published online Dec 12)

Soeters HM, Koivogui L, de Beer L, et al. Infection prevention and control training and capacity building during the Ebola epidemic in Guinea. PLoS One 2018 Feb 28;13(2):e193291

Speranza E, Bixler SL, Altamura LA, et al. A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of fever. Sci Transl Med 2018 Mar 28;10(434):eaaq1016

van Kampen JJA, Tintu A, Russcher H, et al. Ebola virus inactivation by detergents is annulled in serum. J Infect Dis 2017 (published online Aug 14)

Wagenaar BH, Augusto O, Beste J, et al. The 2014-2015 Ebola virus disease outbreak and primary healthcare delivery in Liberia: time-series analyses for 2010-2016. PLoS Med 2018 Feb 20;15(2):e1002508

Weah VD, Doedeh JS, Wiah SQ, et al. Enhancing Ebola virus disease surveillance and prevention in counties without confirmed cases in rural Liberia: experiences from Sinoe County during the flare-up in Monrovia, April to June, 2016. PLoS Curr 2017 Nov 9

Wilkinson AM, Kaiser R, Jalloh MF, et al. Reporting deaths among children aged <5 years after the Ebola virus disease epidemic — Bombali District, Sierra Leone, 2015-2016. MMWR 2017 Oct 20;66(41):1116-8

Winters M, Jalloh MF, Sengeh P, et al. Risk communication and Ebola-specific knowledge and behavior during 2014-15 outbreak, Sierra Leone. Emerg Infect Dis 2018 (published online Jan 8)

Zeng X, Blancett CD, Koistinen KA, et al. Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nat Microbiol 2017 (published online Jul 17)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead Become an underwriter»